These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23718873)

  • 1. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma.
    Xu CC; Biron VL; Puttagunta L; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 May; 42(1):36. PubMed ID: 23718873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
    Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
    ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
    Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
    Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
    Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.
    Clark J; Jeffery CC; Zhang H; Cooper T; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):37. PubMed ID: 26374294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
    Yang X; Hu C; Zhao H; Zhang Z; Zhao L; Yu J; Ni X; Guo H
    Acta Cytol; 2023; 67(3):321-332. PubMed ID: 36513056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased incidence of oropharyngeal cancer and p16 expression.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2011 Sep; 131(9):1008-11. PubMed ID: 21542673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.